Review



svl and sva plasma concentration–time profiles  (Simcyp)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Simcyp svl and sva plasma concentration–time profiles
    Modeling strategy of simvastatin lactone <t>(SVL)</t> and <t>acid</t> <t>(SVA)</t> in the selected platforms. ADME, absorption, distribution, metabolism, and excretion; DDI, drug–drug interaction; DGI, drug–gene interaction; J max , unbound maximum concentration; PBPK, physiologically‐based pharmacokinetic; PK, pharmacokinetic; SVA, simvastatin acid; SVL, simvastatin lactone; V max , maximal rate of metabolism.
    Svl And Sva Plasma Concentration–Time Profiles, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/svl+and+sva+plasma+concentration%E2%80%93time+profiles/svl+and+sva+plasma+concentration+time+profiles/pmc09469690-136-5-18
    Average 90 stars, based on 1 article reviews
    svl and sva plasma concentration–time profiles - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "Does the choice of applied physiologically‐based pharmacokinetics platform matter? A case study on simvastatin disposition and drug–drug interaction"

    Article Title: Does the choice of applied physiologically‐based pharmacokinetics platform matter? A case study on simvastatin disposition and drug–drug interaction

    Journal: CPT: Pharmacometrics & Systems Pharmacology

    doi: 10.1002/psp4.12837

    Modeling strategy of simvastatin lactone (SVL) and acid (SVA) in the selected platforms. ADME, absorption, distribution, metabolism, and excretion; DDI, drug–drug interaction; DGI, drug–gene interaction; J max , unbound maximum concentration; PBPK, physiologically‐based pharmacokinetic; PK, pharmacokinetic; SVA, simvastatin acid; SVL, simvastatin lactone; V max , maximal rate of metabolism.
    Figure Legend Snippet: Modeling strategy of simvastatin lactone (SVL) and acid (SVA) in the selected platforms. ADME, absorption, distribution, metabolism, and excretion; DDI, drug–drug interaction; DGI, drug–gene interaction; J max , unbound maximum concentration; PBPK, physiologically‐based pharmacokinetic; PK, pharmacokinetic; SVA, simvastatin acid; SVL, simvastatin lactone; V max , maximal rate of metabolism.

    Techniques Used: Concentration Assay

    Input parameter for SVL and SVA models
    Figure Legend Snippet: Input parameter for SVL and SVA models

    Techniques Used: Molecular Weight, In Vitro, Permeability, Formulation, Dissolution, Solubility, Clinical Proteomics

    Related Articles

    Clinical Proteomics:

    Article Title: Does the choice of applied physiologically‐based pharmacokinetics platform matter? A case study on simvastatin disposition and drug–drug interaction
    Article Snippet: The f 1 value for SVL and SVA plasma concentration–time profiles across doses was 44 and 78% in Simcyp compared to 38 and 37% in PK‐Sim.

    Concentration Assay:

    Article Title: Does the choice of applied physiologically‐based pharmacokinetics platform matter? A case study on simvastatin disposition and drug–drug interaction
    Article Snippet: The f 1 value for SVL and SVA plasma concentration–time profiles across doses was 44 and 78% in Simcyp compared to 38 and 37% in PK‐Sim.

    Molecular Weight:

    Article Title: Does the choice of applied physiologically‐based pharmacokinetics platform matter? A case study on simvastatin disposition and drug–drug interaction
    Article Snippet: The f 1 value for SVL and SVA plasma concentration–time profiles across doses was 44 and 78% in Simcyp compared to 38 and 37% in PK‐Sim.

    In Vitro:

    Article Title: Does the choice of applied physiologically‐based pharmacokinetics platform matter? A case study on simvastatin disposition and drug–drug interaction
    Article Snippet: The f 1 value for SVL and SVA plasma concentration–time profiles across doses was 44 and 78% in Simcyp compared to 38 and 37% in PK‐Sim.

    Permeability:

    Article Title: Does the choice of applied physiologically‐based pharmacokinetics platform matter? A case study on simvastatin disposition and drug–drug interaction
    Article Snippet: The f 1 value for SVL and SVA plasma concentration–time profiles across doses was 44 and 78% in Simcyp compared to 38 and 37% in PK‐Sim.

    Formulation:

    Article Title: Does the choice of applied physiologically‐based pharmacokinetics platform matter? A case study on simvastatin disposition and drug–drug interaction
    Article Snippet: The f 1 value for SVL and SVA plasma concentration–time profiles across doses was 44 and 78% in Simcyp compared to 38 and 37% in PK‐Sim.

    Dissolution:

    Article Title: Does the choice of applied physiologically‐based pharmacokinetics platform matter? A case study on simvastatin disposition and drug–drug interaction
    Article Snippet: The f 1 value for SVL and SVA plasma concentration–time profiles across doses was 44 and 78% in Simcyp compared to 38 and 37% in PK‐Sim.

    Solubility:

    Article Title: Does the choice of applied physiologically‐based pharmacokinetics platform matter? A case study on simvastatin disposition and drug–drug interaction
    Article Snippet: The f 1 value for SVL and SVA plasma concentration–time profiles across doses was 44 and 78% in Simcyp compared to 38 and 37% in PK‐Sim.

    Software:

    Article Title: Does the choice of applied physiologically‐based pharmacokinetics platform matter? A case study on simvastatin disposition and drug–drug interaction
    Article Snippet: The f 1 value for SVL and SVA plasma concentration–time profiles across doses was 44 and 78% in Simcyp compared to 38 and 37% in PK‐Sim.



    Similar Products

    svl and sva plasma concentration–time profiles  (Simcyp)
    90
    Simcyp svl and sva plasma concentration–time profiles
    Modeling strategy of simvastatin lactone <t>(SVL)</t> and <t>acid</t> <t>(SVA)</t> in the selected platforms. ADME, absorption, distribution, metabolism, and excretion; DDI, drug–drug interaction; DGI, drug–gene interaction; J max , unbound maximum concentration; PBPK, physiologically‐based pharmacokinetic; PK, pharmacokinetic; SVA, simvastatin acid; SVL, simvastatin lactone; V max , maximal rate of metabolism.
    Svl And Sva Plasma Concentration–Time Profiles, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/svl+and+sva+plasma+concentration%E2%80%93time+profiles/svl+and+sva+plasma+concentration+time+profiles/pmc09469690-136-5-18
    Average 90 stars, based on 1 article reviews
    svl and sva plasma concentration–time profiles - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Modeling strategy of simvastatin lactone (SVL) and acid (SVA) in the selected platforms. ADME, absorption, distribution, metabolism, and excretion; DDI, drug–drug interaction; DGI, drug–gene interaction; J max , unbound maximum concentration; PBPK, physiologically‐based pharmacokinetic; PK, pharmacokinetic; SVA, simvastatin acid; SVL, simvastatin lactone; V max , maximal rate of metabolism.

    Journal: CPT: Pharmacometrics & Systems Pharmacology

    Article Title: Does the choice of applied physiologically‐based pharmacokinetics platform matter? A case study on simvastatin disposition and drug–drug interaction

    doi: 10.1002/psp4.12837

    Figure Lengend Snippet: Modeling strategy of simvastatin lactone (SVL) and acid (SVA) in the selected platforms. ADME, absorption, distribution, metabolism, and excretion; DDI, drug–drug interaction; DGI, drug–gene interaction; J max , unbound maximum concentration; PBPK, physiologically‐based pharmacokinetic; PK, pharmacokinetic; SVA, simvastatin acid; SVL, simvastatin lactone; V max , maximal rate of metabolism.

    Article Snippet: The f 1 value for SVL and SVA plasma concentration–time profiles across doses was 44 and 78% in Simcyp compared to 38 and 37% in PK‐Sim.

    Techniques: Concentration Assay

    Input parameter for SVL and SVA models

    Journal: CPT: Pharmacometrics & Systems Pharmacology

    Article Title: Does the choice of applied physiologically‐based pharmacokinetics platform matter? A case study on simvastatin disposition and drug–drug interaction

    doi: 10.1002/psp4.12837

    Figure Lengend Snippet: Input parameter for SVL and SVA models

    Article Snippet: The f 1 value for SVL and SVA plasma concentration–time profiles across doses was 44 and 78% in Simcyp compared to 38 and 37% in PK‐Sim.

    Techniques: Molecular Weight, In Vitro, Permeability, Formulation, Dissolution, Solubility, Clinical Proteomics